BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18439253)

  • 21. Glutathione S-transferase P1 and lung function in patients with alpha1-antitrypsin deficiency and COPD.
    Rodriguez F; de la Roza C; Jardi R; Schaper M; Vidal R; Miravitlles M
    Chest; 2005 May; 127(5):1537-43. PubMed ID: 15888825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. α1-Antitrypsin phenotypes and associated serum protein concentrations in a large clinical population.
    Bornhorst JA; Greene DN; Ashwood ER; Grenache DG
    Chest; 2013 Apr; 143(4):1000-1008. PubMed ID: 23632999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society.
    Abboud RT; Ford GT; Chapman KR;
    Can Respir J; 2001; 8(2):81-8. PubMed ID: 11320399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values.
    Pérez-Rubio G; Jiménez-Valverde LO; Ramírez-Venegas A; Camarena Á; Sansores RH; Flores-Trujillo F; Reséndiz-Hernández JM; Falfán-Valencia R
    Arch Bronconeumol; 2015 Feb; 51(2):80-85. PubMed ID: 25454901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma.
    van Veen IH; ten Brinke A; van der Linden AC; Rabe KF; Bel EH
    Respir Med; 2006 Sep; 100(9):1534-9. PubMed ID: 16476537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study.
    Shaaban R; Kony S; Driss F; Leynaert B; Soussan D; Pin I; Neukirch F; Zureik M
    Respir Med; 2006 Dec; 100(12):2112-20. PubMed ID: 16650972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients.
    Turner AM; Stolk J; Bals R; Lickliter JD; Hamilton J; Christianson DR; Given BD; Burdon JG; Loomba R; Stoller JK; Teckman JH
    J Hepatol; 2018 Aug; 69(2):378-384. PubMed ID: 29572094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of a high saturated fatty acids load on serum concentrations of C-reactive protein, alpha1-antitrypsin, fibrinogen and alpha1-acid glycoprotein in obese women].
    Ramírez Alvarado MM; Sánchez Roitz C; Pérez Díaz A; Millán Brito E
    Nutr Hosp; 2010; 25(1):72-9. PubMed ID: 20204259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophoretic α1-globulin for screening of α1-antitrypsin deficient variants.
    Scarlata S; Santangelo S; Ferrarotti I; Corsico AG; Ottaviani S; Finamore P; Fontana D; Miravitlles M; Incalzi RA
    Clin Chem Lab Med; 2020 Oct; 58(11):1837-1845. PubMed ID: 32324154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum alpha-1 antitrypsin: a noninvasive marker of pouchitis.
    Matalon S; Elad H; Brazowski E; Santo E; Tulchinsky H; Dotan I
    Inflamm Bowel Dis; 2015 Mar; 21(3):589-95. PubMed ID: 25659085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency.
    Banga A; Gildea T; Rajeswaran J; Rokadia H; Blackstone EH; Stoller JK
    Am J Respir Crit Care Med; 2014 Aug; 190(3):274-81. PubMed ID: 25003824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between serum α1-antitrypsin levels and all-cause mortality in the general population: the Nagahama study.
    Tabara Y; Setoh K; Kawaguchi T; Kosugi S; Nakayama T; Matsuda F
    Sci Rep; 2021 Aug; 11(1):17241. PubMed ID: 34446826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of environmental and clinical factors on lung function and respiratory symptoms in adolescents with alpha1-antitrypsin deficiency.
    Piitulainen E; Sveger T
    Acta Paediatr; 1998 Nov; 87(11):1120-4. PubMed ID: 9846912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ).
    Piitulainen E; Tornling G; Eriksson S
    Thorax; 1998 Nov; 53(11):939-43. PubMed ID: 10193391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effects of Inflammation on Alpha 1 Antitrypsin Levels in a National Screening Cohort.
    Sanders CL; Ponte A; Kueppers F
    COPD; 2018 Feb; 15(1):10-16. PubMed ID: 29381093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypes and serum level of alpha-1-antitrypsin in lung cancer.
    Topic A; Ljujic M; Petrovic-Stanojevic N; Dopudja-Pantic V; Radojkovic D
    J BUON; 2011; 16(4):672-6. PubMed ID: 22331720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD.
    Sitkauskiene B; Serapinas D; Blanco I; Fernández-Bustillo E; Janciauskiene S; Sakalauskas R
    Respir Med; 2008 Nov; 102(11):1654-8. PubMed ID: 18722101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three missense variants of metabolic syndrome-related genes are associated with alpha-1 antitrypsin levels.
    Setoh K; Terao C; Muro S; Kawaguchi T; Tabara Y; Takahashi M; Nakayama T; Kosugi S; Sekine A; Yamada R; Mishima M; Matsuda F
    Nat Commun; 2015 Jul; 6():7754. PubMed ID: 26174136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV infection is associated with reduced serum alpha-1-antitrypsin concentrations.
    Bryan CL; Beard KS; Pott GB; Rahkola J; Gardner EM; Janoff EN; Shapiro L
    Clin Invest Med; 2010 Dec; 33(6):E384-9. PubMed ID: 21134340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ).
    Piitulainen E; Eriksson S
    Eur Respir J; 1999 Feb; 13(2):247-51. PubMed ID: 10065663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.